Naito S, Saito A, Furukawa Y, Hata T, Nakada Y, Muramatsu S, Ide J
Medicinal Chemistry Research Laboratories, Sankyo Co., Ltd., Tokyo, Japan.
J Antibiot (Tokyo). 1994 Jul;47(7):812-20. doi: 10.7164/antibiotics.47.812.
Epoxidation reactions (MCPBA epoxidation and Sharpless epoxidation) were examined as a means of chemically modifying milbemycins as part of our program for discovering anthelmintics. 8,9-Epoxy-, 14,15-epoxy-, 8,9-14,15-diepoxy-, and 3,4-8,9-14,15-triepoxymilbemycin A4 were selectively obtained from milbemycin A4 and its derivatives, in which either the C-5 and C-7 hydroxyl groups or C-5 alone were protected as appropriate by a silyl ether (in the former case) or a carbonyl group. Further silylation or epoxidation on these epoxidized compounds indicated that the configuration of each epoxide moiety of the mono- and diepoxides is in accord with that of the corresponding epoxide moiety of the triepoxide. Furthermore, in order to confirm the absolute configurations of these epoxide functionalities, an X-ray analysis of a carbamate derivative from the triepoxymilbemycin was conducted.
作为我们发现驱虫药计划的一部分,我们研究了环氧化反应(间氯过氧苯甲酸环氧化和夏普莱斯环氧化)作为化学修饰米尔倍霉素的一种方法。从米尔倍霉素A4及其衍生物中选择性地获得了8,9-环氧-、14,15-环氧-、8,9-14,15-二环氧-和3,4-8,9-14,15-三环氧米尔倍霉素A4,其中C-5和C-7羟基或仅C-5通过硅醚(在前一种情况下)或羰基进行了适当的保护。对这些环氧化化合物进行进一步的硅烷化或环氧化表明,单环氧化物和二环氧化物的每个环氧化物部分的构型与三环氧化物相应环氧化物部分的构型一致。此外,为了确定这些环氧化物官能团的绝对构型,对三环氧米尔倍霉素的氨基甲酸酯衍生物进行了X射线分析。